Ruxolitinib ≥99% (par HPLC)
Fournisseur: Enzo Life Sciences
ENZCHM1560005
ENZCHM1560010
ENZOENZCHM1560005EA
165
EUR
ENZOENZCHM1560005
ENZOENZCHM1560010
Ruxolitinib ≥99% (par HPLC)
Ruxolitinib
JAK inhibitor
Ruxolitinib is a Janus kinase inhibitor with IC50 values of 2.7 and 4.5, respectively, for JAK1 and JAK2.
Formule:
C₁₇H₁₈N₆ |
Numéro MDL:
MFCD12031592 Numéro CAS: 941678-49-5 |
|
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...